Plant drugs: Transcending the mescaline biosynthesis.
Vincent Courdavault, Nicolas Papon
Current biology : CB August 19, 2024 DOI: 10.1016/j.cub.2024.06.061 via PubMed
Summary
AI-generated from the abstractThe complete metabolic pathway for the biosynthesis of the psychedelic compound mescaline in the peyote cactus has been deciphered. This discovery suggests that biotechnological strategies could be developed to produce mescaline sustainably, addressing limitations in current knowledge of how medicinal compounds are made in plants.
Study at a glance
| Characteristics | Experimental study Peer reviewed |
|---|---|
| Population | Peyote cactus |
| Keywords | Psychedelics Plant biochemistry Natural compounds Conservation biology Medicinal research |
| Citations | 1 |
| Key finding | The complete metabolic pathway for mescaline biosynthesis in peyote has been identified, enabling potential biotechnological production. |
Abstract
Our knowledge of the biosynthesis of medicinal compounds from plants remains limited. A new study has deciphered the complete metabolic pathway leading to the biosynthesis of the psychedelic mescaline in the cactus peyote, suggesting the development of biotechnological strategies for a sustainable supply of this important plant drug.